Clinical Trials: Lowereing A1C, Weight Change & CV Data, HCP

See results from clinical trials with Trulicity when assessed for A1C reduction, weight change and CV risk reduction.

Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial. - Abstract - Europe PMC

IJERPH, Free Full-Text

Clinical Trials: Lowereing A1C, Weight Change & CV Data, HCP

PDF) A pragmatic randomized clinical trial of insulin glargine 300 U/mL versus first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of ACHIEVE Control

Clinical Trials: Lowereing A1C, Weight Change & CV Data, HCP

Clinical Trials: Lowereing A1C, Weight Change & CV Data, HCP

Diabetes Canada Clinical Practice Guidelines

SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice

Diabetes Canada Clinical Practice Guidelines

Frontiers Changes in body weight and cardiovascular risk factors in a Chinese population with type 2 diabetes mellitus: a longitudinal study

A1C and Weight Results RYBELSUS® (semaglutide) tablets 7 mg or 14 mg

PDF) Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)